Fresenius Medical Care AG & Co. KGaA (FMEA) - Total Liabilities

Latest as of March 2026: €17.26 Billion EUR ≈ $20.18 Billion USD

Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FMEA) has total liabilities worth €17.26 Billion EUR (≈ $20.18 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Fresenius Medical Care AG & Co. KGaA (FMEA) net asset momentum to track the company's year-over-year net asset growth rate.

Fresenius Medical Care AG & Co. KGaA - Total Liabilities Trend (2016–2025)

This chart illustrates how Fresenius Medical Care AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. See FMEA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Fresenius Medical Care AG & Co. KGaA Competitors by Total Liabilities

The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their total liabilities.

Company Country Total Liabilities
Ningbo Zhoushan Port Co Ltd
SHG:601018
China CN¥30.31 Billion
Aker ASA
OL:AKER
Norway Nkr47.56 Billion
Groep Brussel Lambert NV
BR:GBLB
Belgium €11.68 Billion
Hyundai Rotem Co
KO:064350
Korea ₩3.64 Trillion
Smithfield Foods, Inc. Common Stock
NASDAQ:SFD
USA $4.80 Billion
Keyera Corp.
TO:KEY
Canada CA$10.70 Billion
Harmony Gold Mining Company Limited
F:HAM
Germany €62.42 Billion
Eneva S.A
SA:ENEV3
Brazil R$36.59 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Fresenius Medical Care AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see FMEA market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.55 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fresenius Medical Care AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fresenius Medical Care AG & Co. KGaA (2016–2025)

The table below shows the annual total liabilities of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €16.72 Billion
≈ $19.55 Billion
-6.06%
2024-12-31 €17.80 Billion
≈ $20.81 Billion
-6.83%
2023-12-31 €19.10 Billion
≈ $22.33 Billion
-5.92%
2022-12-31 €20.30 Billion
≈ $23.74 Billion
-0.41%
2021-12-31 €20.39 Billion
≈ $23.84 Billion
+5.32%
2020-12-31 €19.36 Billion
≈ $22.63 Billion
-1.77%
2019-12-31 €19.71 Billion
≈ $23.04 Billion
+47.73%
2018-12-31 €13.34 Billion
≈ $15.60 Billion
+1.09%
2017-12-31 €13.20 Billion
≈ $15.43 Billion
-10.32%
2016-12-31 €14.72 Billion
≈ $17.20 Billion
--

About Fresenius Medical Care AG & Co. KGaA

F:FMEA Germany Medical Care Facilities
Market Cap
$13.69 Billion
€11.71 Billion EUR
Market Cap Rank
#2250 Global
#467 in Germany
Share Price
€21.80
Change (1 day)
+2.83%
52-Week Range
€17.70 - €23.60
All Time High
€37.68
About

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more